Your session is about to expire
← Back to Search
Behavioral Intervention
Enhanced Milieu Teaching for Language Disorders
N/A
Recruiting
Led By Rebecca M Alper, Ph.D., CCC-SLP
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Children in the Typically Developing Group (TD) must be aged 1 year 4 months - 1 year 8 months 30 days at the start of testing
Children in the DLD+ASD Group must be aged 2 years 6 months - 4 years 0 months 0 days at the start of testing
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (single timepoint)
Awards & highlights
Study Summary
This trial looks at how well parents can learn how to improve their child's language skills, and what predicts how well they will do.
Who is the study for?
This trial is for children with Autism Spectrum Disorder or Language Disorder, and typically developing peers. Participants must be English dominant, have no diagnosed hearing loss, and live near Temple University in Pennsylvania or in Wisconsin. Parents need internet access for videoconferencing and must be able to consent.Check my eligibility
What is being tested?
The study tests Enhanced Milieu Teaching (EMT), a parent training intervention aimed at improving early language skills in children at risk due to developmental disorders. It compares outcomes between those receiving EMT and a group without intervention.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. However, there may be varying levels of stress or frustration associated with the training process.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child is between 1 year 4 months and 1 year 8 months old.
Select...
My child is between 2.5 and 4 years old.
Select...
My child is between 2.5 and 4 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to post-treatment (five weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to post-treatment (five weeks)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Parental Language Stimulation Strategies (Study 1; Remote)
Parental Language Stimulation Strategies (Study 2; Remote)
Secondary outcome measures
Adult-Child Conversational Turns (Study 1; Remote)
Adult-Child Conversational Turns (Study 2; Remote)
Trial Design
5Treatment groups
Experimental Treatment
Group I: Typically Developing Children Study 2 (TD2)Experimental Treatment1 Intervention
No-intervention comparison group measured over time.
Group II: Typically Developing Children Study 1 (TD1)Experimental Treatment1 Intervention
No-intervention group for observational data comparison.
Group III: Children with Dev Language Disorder Study 2 (DLD2)Experimental Treatment1 Intervention
Enhanced Milieu Teaching
Group IV: Children with Dev Language Disorder Study 1 (DLD1)Experimental Treatment1 Intervention
No-intervention group for observational data comparison.
Group V: Children with Autism Spectrum Disorders Study 2 (ASD+DLD 2)Experimental Treatment1 Intervention
Enhanced Milieu Teaching
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhanced Milieu Teaching
2009
N/A
~100
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,187 Previous Clinical Trials
3,169,147 Total Patients Enrolled
8 Trials studying Autism Spectrum Disorder
631 Patients Enrolled for Autism Spectrum Disorder
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
330 Previous Clinical Trials
178,121 Total Patients Enrolled
10 Trials studying Autism Spectrum Disorder
646 Patients Enrolled for Autism Spectrum Disorder
Temple UniversityLead Sponsor
297 Previous Clinical Trials
82,623 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
286 Patients Enrolled for Autism Spectrum Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a parent and I am 18 years old or older.My child is between 1 year 4 months and 1 year 8 months old.Kids in the TD Group must show typical language skills by meeting certain criteria on specific tests for words and sentences and cognitive abilities.My child is between 2.5 and 4 years old.My child is between 2.5 and 4 years old.Children in the DLD Group must be at risk for having trouble with language by meeting specific requirements on two tests, the Mac Arthur-Bates Communicative Development Inventory-III (CDI-III) and the Cognition subtest of the DAYC-2.Children in the DLD+ASD Group must show specific language and thinking skills on certain tests to be considered at risk for persistent language disorder.I, as a parent, do not have any major health issues other than ASD or speech-language disorders.Children in the DLD Group should not have been diagnosed with hearing loss by their parents, or if not tested, there should be no concerns about their hearing.My parents do not have diagnosed hearing loss or concerns about their hearing.
Research Study Groups:
This trial has the following groups:- Group 1: Typically Developing Children Study 2 (TD2)
- Group 2: Children with Dev Language Disorder Study 2 (DLD2)
- Group 3: Children with Autism Spectrum Disorders Study 2 (ASD+DLD 2)
- Group 4: Typically Developing Children Study 1 (TD1)
- Group 5: Children with Dev Language Disorder Study 1 (DLD1)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
To what extent has this trial been populated with participants?
"Affirmative, the clinicaltrials.gov website confirms that this trial is presently accepting volunteers. This research project was first advertised on March 22nd 2021 and underwent its most recent update on May 5th 2022. It seeks to recruit 350 participants from a single site."
Answered by AI
Are any new participants currently being accepted into this medical research?
"Clinicaltrials.gov provides evidence that this clinical trial is currently searching for volunteers to take part; the experiment was initially published on March 22nd 2021 and its details were recently modified on May 5th 2022."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger